Cairo – Mubasher: Arab Drug Company’s profits rose in the first nine months of fiscal year 2016/2017 by 424% to EGP 22.9 million, compared to EGP 4.37 million for the same period in FY15/16.
Sales increased in the first nine months of FY17/18 to EGP 262.16 million from EGP 189.1 million in the same period of the previous year, according to a bourse filing released on Thursday.
